Caring Brands (CABR) Income from Continuing Operations (2024 - 2026)
Caring Brands (CABR) posted quarterly Income from Continuing Operations of 3439427.0 for Q1 2026, down 537.2% year-over-year from 786690.0 in Q1 2025, and up 7.94% quarter-over-quarter from 3736070.0 in Q4 2025.
Caring Brands (CABR) Income from Continuing Operations (2024 - 2026) Analysis & Trends
Caring Brands' Income from Continuing Operations history runs 3 years deep, the most recent figure standing at 3439427.0 for Q1 2026.
- In Q1 2026, Income from Continuing Operations fell 537.2% year-over-year to 3439427.0; the TTM figure through Mar 2026 stood at 9361771.0 (changed N/A YoY), while the FY2025 annual figure was 7434669.0, down 2740.12% from the prior year.
- Income from Continuing Operations for Q1 2026 stood at 3439427.0, up from 3736070.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 428906.0 in Q3 2024, with the low at 3736070.0 in Q4 2025.
- The 3-year median for Income from Continuing Operations is 1254647.5 (2024), against an average of 1775578.0.
- The sharpest annual moves came in 2025 and 2026: Income from Continuing Operations sank 283.88% in 2025, then plunged 537.2% in 2026.
- Caring Brands' Income from Continuing Operations stood at 862791.0 in 2024, then tumbled by 333.02% to 3736070.0 in 2025, then grew by 7.94% to 3439427.0 in 2026.
- Business Quant data shows CABR's Income from Continuing Operations at 3439427.0 in Q1 2026, 3736070.0 in Q4 2025, and 1646504.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -576.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 866.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.33 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 333.00 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -118.80 Mn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 144.40 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 54.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Caring Brands | 11.78 Mn | 9.96 Mn | - | -638,776.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.45 Mn |
| Mar 31, 2026 | -3.44 Mn |
| Dec 31, 2025 | -3.74 Mn |
| Sep 30, 2025 | -1.65 Mn |
| Mar 31, 2025 | -539,770.00 |
| Dec 31, 2024 | -862,791.00 |
| Sep 30, 2024 | -428,906.00 |